Introduction The DEA submitted a rule titled “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” for review on October 10, 2024. The rule was posted to the Federal Register and extends the date of prescribing flexibilities as we use them currently through December 31, 2025. Developments in Federal Regulation for Telemedicine […]
Introduction The DEA submitted a rule titled “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” for review on October 10, 2024. The rule was posted to the Federal Register and extends the date of prescribing flexibilities as we use them currently through December 31, 2025. Developments in Federal Regulation for Telemedicine […]
